Posts
-
Drug Demonstrates Poor Efficacy in Advanced Bladder Cancer
An FDA-approved monoclonal antibody drug used to treat advanced bladder cancer demonstrated poor efficacy in a recent clinical trial.
-
Northwestern Investigators Pursue Strategies to Combat COVID-19
Northwestern Medicine scientists and clinicians have continued to investigate methods to combat the disease, including strategies to conduct clinical trials during a pandemic, studying neurologic symptoms in children and reflecting on the importance of professional medical organizations during a public health crisis.
-
Ahya Honored with Service Award from National Kidney Foundation
Shubhada Ahya, MD, has received the Medical Advisory Board Distinguished Service Award from the National Kidney Foundation.